Leiden, 1995 New Engl. J. Med. 333:871-873. |
Mulligan, 1993 Science 260:926-932. |
Brenner, 1994 Immunomethods 5:204-210. |
Banapour et al., "The AIDS-Associated Retrovirus is Not Sensitive to Lysis or Inactivation by Human Serum" Virology, 152:268-271, 1986. |
Barbacid et al., "Humans Have Antibodies Capable of Recognizing Oncoviral Glycoproteins: Demonstration that these Antibodies are Formed in Response to Cellular Modification of Glycoproteins Rather than as Consequence of Exposure to Virus" Proc. Natl. Acad. Sci. USA, 77(3):1617-21, 1980. |
Bartholomew et al., "Lysis of oncornaviruses by human serum" J Exp Med, 147:844-853, 1978. |
Bartholomew and Esser, "Mechanism of antibody-independent activation of the first component of complement (C1) on retrovirus membranes" Biochem, 19:2847-2853, 1980. |
Cooper et al., "Lysis of RNA tumor viruses by human serum: Direct antibody-independent triggering of the classical complement pathway" J Exp Med, 144:970-984, 1976. |
Cooper et al., "Genetically Engineered Pigs" Lancet, 342:682-683, 1993. |
Cornetta et al., "Amphotropic Murine Leukemia Retrovirus is not an Acute Pathogen for Primates" Human Gene Therapy, 1:15-30, 1990. |
Culver et al., "In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors" Science, 256:1550-1552, 1992. |
Donahue et al., "Helper Virus Induced T Cell Lymphoma in Nonhuman Primates after Retroviral Mediated Gene Transfer" J Exp Med, 176:1125-1135, 1992. |
Galili et al., "Evolutionary relationship between the natural anti-Gal antibody and the Gal.alpha.1.fwdarw.3Gal epitope in primates" Proc Natl Acad Sci, USA, 84:1369-1373, 1987. |
Galili et al., "Man, Apes, and Old World Monkeys Differ from Other Mammals in the Expression of .alpha.-Galactosyl Epitopes on Nucleated Cells" J Biol Chem, 263:17755-17762, 1988. |
Galili et al., "Gene Sequences Suggest Inactivation of .alpha.-1,3-Galactosyltransferase in Catarrhines after the Divergence of Apes from Monkeys" Proc Natl Acad Sci, USA, 88:7401-7404, 1991, Apr. 30, 1998. |
Galili et al., "Evolution and Pathophysiology of the Human Natural Anti-.alpha.-galactosyl IgG (Anti-Gal) Antibody" Springer Semin Immunopathol, 15:155-171, 1993. |
Geyer et al., "Major Oligosaccharides in the Glycoprotein of Friend Murine Leukemia Virus: Structure Elucidation by One- and Two-Dimensional Proton Nuclear Magnetic Resonance and Methylation Analysis" Biochemistry, 23:5628-5637, 1984, Apr. 30, 1998. |
Hamadeh et al., "Human Natural Anti-Gal IgG Regulates Alternative Complement Pathway Activation on Bacterial Surfaces" J Clin Invest, 89:1223-1235, 1992. |
Hoshino et al., "Human T-Cell Leukaemia Virus is not Lysed by Human Serum" Nature, 310:324-325, 1984. |
Isaacs et al., "Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence" Proc Natl Acad Sci, USA, 89:628-632, (1992). |
Joziasse et al., "Bovine .alpha.1.fwdarw.3-Galactosyltransferase: Isolation and Characterization of a cDNA Clone" J Biol Chem, 264:14290-14297, 1989. |
Kohn et al., "Retroviral-Mediated Gene Transfer into Mammalian Cells" Blood Cells, 13:285-298, 1987. |
Larsen et al., "Molecular Cloning, Sequence, and Expression of a Human GDP-L-fucose:.beta.-D-galactoside 2-.alpha.-L-fucosyltransferase cDNA that Can Form the H Blood Group Antigen" Proc Natl Acad Sci, USA, 87:6674-6678, 1990. |
Lowe, "Molecular Cloning, Expression, and Uses of Mammalian Glycosyltransferases" Semin Cell Biol, 2:289-307, 1991. |
Lower et al., "Heterophil Human Antibodies Recognize Oncovirus Envelope Antigens: Epidemiological Parameters and Immunological Specificity of the Reaction" Virology, 109:409-417, 1981. |
McNearney et al., "Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity" J Exp Med, 166:1525-1535, 1987. |
Martinez et al., "Partial Reconstitution of Replication-Competent Retrovirus in Helper Cells with Partial Overlaps Between Vector and Helper Cell Genomes" Human Gene Therapy, 7:705-712, 1996. |
Neethling et al., "Protection of pig kidney (PK15) cells from the cytotoxin effect of anti-pig antibodies by .alpha.-galactosyl oligosaccharides" Transplantation, 57:959-963, 1994. |
Ram et al., "Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors " J Neurosurg, 79:400-407, 1993. |
Repik et al., "Differential host-dependent expression of .alpha.-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model" J Gen Virol, 75:1177-1181, 1994. |
Rother et al., "Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri" J Virol, 68:730-737, 1994. |
Rother et al., "Protection of Retroviral Vector Particles in Human Blood through Complement Inhibition" Human Gene Therapy, 6:429-435, 1995. |
Rother et al., "A Novel Mechanism of Retrovirus Inactivation in Human Serum Mediated by Anti-.alpha.-Galactosyl Natural Antibody" J Exp Med, 182:1345-1355, 1995. |
Sandrin et al., "Biochemical Features of Pig to Human Xenografts" J Leukocyte Biol, O (Suppl.) :66, 1993. |
Sandrin et al., "Anti-Pig IgM Antibodies in Human Serum React Predominantly with Gal (.alpha.1-3)Gal Epitopes" Proc Natl Acad Sci, USA, 90:11391-11395, 1993. |
Sandrin et al., "Gal .alpha.(1-3) Gal, the Major Xenoantigen(s) Recognized in Pigs by Human Natural Antibodies" Immunol Reviews, 141:160-190, 1994. |
Sherwin et al., "Complement-Mediated Lysis of Type-C Virus: Effect of Primate and Human Sera on Various Retroviruses" Int J Cancer, 21:6-11, 1978. |
Snyder et al., "Specificity of Human Antibodies to Oncovirus Glycoprotiens: Recognition of Antigen by Natural Antibodies against Carbohydrate Structures" Proc Natl Acad Sci, USA, 77:1622-1626, 1980. |
Spear et al., "Direct Binding of Complement Component C1q to Human Immunodeficiency Virus (HIV) and Human T Lymphotrophic Virus-I (HTLV-|) Coinfected Cells" AIDS Research Human Retroviruses, 7:579-585. 1991. |
Takeuchi et al., "Type C Retrovirus Inactivation by Human Complement Is Determined by both the Viral Genome and the Producer Cell" J Virol, 68:8001-8007, 1994. |
Thall et al., "Distribution of Gal.alpha.1.fwdarw.3Gal.beta.1.fwdarw.4GlcNAc Residues on Secreted Mammalian Glycoproteins (Thyroglobulin, Fibrinogen, and Immunoglobulin G) as Measured by a Sensitive Solid-Phase Radioimmunoassay" Biochemistry, 29:3959-3965, 1990. |
Thiry et al., "Factors which Influence Inactivation of Vesicular Stomatitis Virus by Fresh Human Serum" Virology, 87:384-393, 1978. |
Vaughn et al., "Biochemical Analysis of Pig Xenoantigens Detected by Human Antibodies" Transplantation Proc, 25:2919-2920, 1993. |
Welsh et al., "Human serum lyses RNA tumour viruses" Nature, 257:612-614, 1975. |
Welsh et al., "Inactivation and lysis of oncornaviruses by human serum" Virology, 74:432-440, 1976. |
Widner and Brundin, "Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis" Brain Res Rev, 13:287-324, 1988. |